Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 4.04% is 79% below its 4-year average of 18.82%, near the low end of its 4-year range (4.04%–83.98%).
As of the fiscal period ended Tuesday, March 31, 2026. 81.95% below its 12-month average of 22.36%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
4.04%
OPERATING MARGIN AVG TTM
22.36%
OPERATING MARGIN AVG 3Y
13.39%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-81.95%
CURRENT VS 3Y AVG
-69.86%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.61%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-74.15%
vs the sector median at left
Solventum Corporation
Market Cap
$13.51B
Operating Margin
4.04%
TTM Avg
22.36%
3Y Avg
13.39%
5Y Avg
N/A
Market Cap
$13.71B
Operating Margin
11.77%
TTM Avg
17.41%
3Y Avg
16.25%
5Y Avg
15.86%
Market Cap
$12.32B
Operating Margin
12.41%
TTM Avg
13.70%
3Y Avg
16.38%
5Y Avg
21.25%
Market Cap
$11.96B
Operating Margin
14.44%
TTM Avg
15.23%
3Y Avg
16.08%
5Y Avg
17.45%
Market Cap
$11.57B
Operating Margin
-2.65%
TTM Avg
-1.31%
3Y Avg
-6.02%
5Y Avg
0.15%
Market Cap
$11.31B
Operating Margin
17.48%
TTM Avg
16.20%
3Y Avg
12.06%
5Y Avg
10.90%
Market Cap
$11.21B
Operating Margin
12.70%
TTM Avg
13.11%
3Y Avg
19.83%
5Y Avg
21.02%
Market Cap
$10.91B
Operating Margin
11.77%
TTM Avg
9.13%
3Y Avg
12.39%
5Y Avg
13.51%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.51B | 4.04% | 22.36% | 13.39% | N/A |
| The Cooper Companies, Inc. (COO)vs › | $13.71B | 11.77% | 17.41% | 16.25% | 15.86% |
| Revvity, Inc. (RVTY)vs › | $12.32B | 12.41% | 13.70% | 16.38% | 21.25% |
| Align Technology, Inc. (ALGN)vs › | $11.96B | 14.44% | 15.23% | 16.08% | 17.45% |
| DaVita Inc. (DVA)vs › | $15.11B | 15.01% | 15.52% | 13.94% | 14.32% |
| Baxter International Inc. (BAX)vs › | $11.57B | -2.65% | -1.31% | -6.02% | 0.15% |
| Insulet Corp. (PODD)vs › | $11.31B | 17.48% | 16.20% | 12.06% | 10.90% |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 12.70% | 13.11% | 19.83% | 21.02% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | 11.77% | 9.13% | 12.39% | 13.51% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -2.02% | -7.24% | -2.92% | -1.15% |
Gross Margin
53.7%
Operating Margin
4.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | 4.04% |
| 2025-12-31 | 83.98% |
| 2025-09-30 | 6.54% |
| 2025-06-30 | 9.90% |
| 2025-03-31 | 7.34% |
| 2024-12-31 | 6.55% |
| 2024-09-30 | 13.21% |
| 2024-06-30 | 11.73% |
| 2024-03-31 | 18.90% |
| 2023-12-31 | 19.94% |
| 2023-09-30 | 24.30% |
| 2023-06-30 | 20.09% |
| 2023-03-31 | 18.15% |
| 2022-12-31 | 11.17% |
| 2022-09-30 | 21.06% |
| 2022-06-30 | 21.50% |
| 2022-03-31 | 21.50% |
